MoMMent
Recruiting
300 enrolled
LTFS
Enrolling by invitation
150 enrolled
REALiTEC/TAL
Recruiting
900 enrolled
A Study of Ninlaro in Real World Clinical Practice in China
Completed
482 enrolled
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
Recruiting
75 enrolled
A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
Not yet recruiting
30 enrolled
MUST
Active not recruiting
250 enrolled
MYRIAM
Recruiting
2,200 enrolled
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Recruiting
50 enrolled
MMExFFPE
Not yet recruiting
15 enrolled
CAMPERR
Recruiting
7,000 enrolled
SEATTLE
Active not recruiting
75 enrolled
A Study of NINLARO® in Chinese Adults With Multiple Myeloma
Active not recruiting
72 enrolled
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Active not recruiting
2,555 enrolled
A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant
Active not recruiting
911 enrolled
Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).
Active not recruiting
150 enrolled
Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.
Active not recruiting
1 enrolled
LEADER
Active not recruiting
357 enrolled
A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan
Completed
7 enrolled
IONA-MM
Active not recruiting
583 enrolled
A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
Completed
633 enrolled 15 charts
Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
Recruiting
1,500 enrolled
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies
Completed
4 enrolled
Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma
Completed
62 enrolled
Pomalyst PMS
Completed
397 enrolled
LocoMMotion
Completed
254 enrolled
Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice
Completed
127 enrolled
SANGUINE
Recruiting
3,000 enrolled
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Terminated
4,253 enrolled 21 charts
Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy
Not yet recruiting
1,500 enrolled
Multiple Myeloma Patient Registry
Terminated
85 enrolled
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
Terminated
58,213 enrolled
A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea
Recruiting
15 enrolled
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Recruiting
1,000 enrolled
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
Completed
514 enrolled 16 charts
PC002
Not yet recruiting
210 enrolled
MYLENE
Completed
96 enrolled
Incidence of Hyperpigmentation in Black Patients With Multiple Myeloma Treated With Immunomodulatory Drugs
Completed
4,204 enrolled
The clonoSEQ® Watch Registry
Terminated
465 enrolled
A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)
Completed
191 enrolled
DOrianT
Completed
240 enrolled
Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma
Terminated
33 enrolled
A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan
Completed
330 enrolled 8 charts
A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma
Completed
508 enrolled 16 charts
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Recruiting
20,000 enrolled
Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma
Recruiting
450 enrolled
ABE-DESCART
Active not recruiting
350 enrolled
FIRST-NIS
Completed
172 enrolled
Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer
Completed
208 enrolled
A Study of People With Multiple Myeloma (MM) in Portugal (CharisMMa-Portugal)
Completed
62 enrolled